NL
DE
Our purpose
We aim to unravel the pathophysiological basis of hematological disease, understand the biological consequences and define possibilities for therapeutic intervention.
Goals
- Improve diagnostic, predictive and monitoring modalities and prevent disease progression.
- Develop novel targeted forms of treatment, both immunological (antibody/DC vaccines/CART/NK) and chemical (PROTACS, small molecules) and perform investigator-initiated phase I/II trials.
- Improve quality of life by reducing early and late treatment-related toxicity and avoiding disease progression.
- Enhance patient engagement and shared decision making by personalized, eHealth-based care platforms.
